1. Home
  2. TLSI vs BVFL Comparison

TLSI vs BVFL Comparison

Compare TLSI & BVFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSI
  • BVFL
  • Stock Information
  • Founded
  • TLSI 2010
  • BVFL 1873
  • Country
  • TLSI United States
  • BVFL United States
  • Employees
  • TLSI N/A
  • BVFL N/A
  • Industry
  • TLSI Medical Specialities
  • BVFL Savings Institutions
  • Sector
  • TLSI Health Care
  • BVFL Finance
  • Exchange
  • TLSI Nasdaq
  • BVFL Nasdaq
  • Market Cap
  • TLSI 160.4M
  • BVFL 160.4M
  • IPO Year
  • TLSI N/A
  • BVFL N/A
  • Fundamental
  • Price
  • TLSI $5.21
  • BVFL $15.30
  • Analyst Decision
  • TLSI Strong Buy
  • BVFL
  • Analyst Count
  • TLSI 5
  • BVFL 0
  • Target Price
  • TLSI $10.90
  • BVFL N/A
  • AVG Volume (30 Days)
  • TLSI 41.1K
  • BVFL 20.5K
  • Earning Date
  • TLSI 05-15-2025
  • BVFL 07-17-2025
  • Dividend Yield
  • TLSI N/A
  • BVFL N/A
  • EPS Growth
  • TLSI N/A
  • BVFL N/A
  • EPS
  • TLSI N/A
  • BVFL 1.06
  • Revenue
  • TLSI $32,141,000.00
  • BVFL $38,257,000.00
  • Revenue This Year
  • TLSI $55.13
  • BVFL N/A
  • Revenue Next Year
  • TLSI $50.71
  • BVFL N/A
  • P/E Ratio
  • TLSI N/A
  • BVFL $14.67
  • Revenue Growth
  • TLSI 46.20
  • BVFL 1.89
  • 52 Week Low
  • TLSI $3.50
  • BVFL $11.10
  • 52 Week High
  • TLSI $7.55
  • BVFL $18.19
  • Technical
  • Relative Strength Index (RSI)
  • TLSI 46.54
  • BVFL 43.45
  • Support Level
  • TLSI $4.95
  • BVFL $15.40
  • Resistance Level
  • TLSI $5.68
  • BVFL $15.82
  • Average True Range (ATR)
  • TLSI 0.40
  • BVFL 0.24
  • MACD
  • TLSI 0.01
  • BVFL -0.07
  • Stochastic Oscillator
  • TLSI 39.74
  • BVFL 4.48

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About BVFL BV Financial Inc.

BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. The Company's sources of revenue are derived from interest and dividends earned on loans and investment securities.

Share on Social Networks: